Association of MTHFR gene polymorphism (rs1801133) with Type 2 Diabetic Iraqi population

Authors

  • Salih M. Alkhafaji Kufa University, College of Medicine, Anatomy Department. Author
  • Anwar M. Aljanabi Kufa University, College of Medicine, Biochemistry Department. Author

DOI:

https://doi.org/10.63939/m41cpz28

Keywords:

MTHFR, gene, C677T, polymorphism, T2DM

Abstract

Background: Type 2 Diabetes Mellitus is a complex of endocrine metabolic disorder. It is believed that polymorphism of Methylenetetrahydrofolate reductase (MTHFR) C677T related to type 2 diabetes mellitus. However, results are conflicted from different ethnic and races. This study aimed to evaluate the relationship between MTHFR (rs1801133) gene polymorphism and type 2 diabetes mellitus.

Methods:  This case-control study was included 100 patients were diagnosed with type 2 diabetes mellitus (T2DM) cases and 100 healthy control individuals. The blood sample was collected for estimation of biochemical parameters for analysis among the T2DM cases and healthy control groups. DNA extraction from whole blood was done to study the MTHFR gene polymorphism by RFLP-PCR method.

Results: There were significant difference in genotype distribution among Type2 diabetic patients and control group. Compared with CC wild genotype, CT heterozygous genotype (OR= 5.7, 95% Cl= 3.0-11.0 and P=0.0001) and TT homozygous genotype (OR=4.3, CI=1.5-11.9 and P=0.0005). The T allele frequency increased the risk in diabetic patients by three folds when compared with C allele (OR= 3.6, C. I=2.2-5.5, P= 0.0001), suggested that the effect of MTHFR point mutation on type 2 diabetes mellitus implicated with increased risk of disease.

Conclusion; Our results indicate that polymorphism in MTHFR C677T plays significant role in type II diabetes mellitus risk for Iraqi populations

Downloads

Download data is not yet available.

References

1. Daniel E. P., Essa H., Pascale S. Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction. Diabetology & Metabolic Syndrome. 2017; 9:19.

2. Chehadeh, S.W.E.H., Jelinek, H.F., Al Mahmeed, W.A., Tay, G.K., Odama, U.O., Elghazali, G.E., Al Safar, H.S. Relationship between MTHFR C677T and A1298C gene polymorphisms and complications of type 2 diabetes mellitus in an Emirati population. Meta Gene. 2016; 9: 70–75.

3. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–57.

4. (https:// www. who. int/ health- topics/ diabe tes)

5. Ali O. Genetics of type 2 diabetes. World J Diabetes. 2013;4(4):114–23.

6. Brandalize, A.P.C., Bandinelli, E., Borba, J.B., Felix, T.M., Roisenberg, I., Schuler-Faccini, L. Polymorphisms in genes MTHFR, MTR and MTRR are not risk factors for cleft lip/palate in South Brazil. Braz. J. Med. Biol. Res. 2007; 40 (6), 787–791.

7. Ahmed A. M., Doaa H. H. et al. Homocysteine levels in schizophrenia and affective disorders focus on cognition. Frontiers in Behavioral Neuroscince. 2014; 00343.

8. Won-Cheol Park, and Jeong-Hwan Chang. Clinical Implications of Methylenetetrahydrofolate Reductase Mutations and Plasma Homocysteine Levels in Patients with Thromboembolic Occlusion. Vascular Specialist International 2014; 30(4): 113-119

9. Stover, P.J. One-carbon metabolism-genome interactions in folate-associate pathologies. J. Nutr. 2009; 139, 2402-2405.

10. Alexander S., Susanna M., Holger L., Peter M. and Michael L. Haplotype analysis of the 5,10- methylenetetrahydrofolate reductase (MTHFR) c.1298A>C (E429A) polymorphism. BMC Research Notes 2011; 4:439

11. Friso, S., Choi, S.W., Girelli, D., Mason, J.B., Dolnikowski, G.G., Bagley, P.J., Olivieri, O., Jacques, P.F., Rosenberg, I.H., Corrocher, R., et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U. S. A. 2002; 99, 5606–5611.

12. Quinlivan, E.P., Davis, S.R., Shelnutt, K.P., Henderson, G.N., Ghandour, H., Shane, B., Selhub, J., Bailey, L.B., Stacpoole, P.W., Gregory, J.F. Methylenetetrahydrofolate reductase 677C →T polymorphism and folate status affect one-carbon incorporation inthuman DNA deoxynucleosides. J. Nutr. 2005; 135, 389-396.

13. Al-Khafaji S M. Evaluation of FokI polymorphisms of VDR gene in Iraqi patients with colorectal cancer. International Journal of Advanced Research. 2015; 3 (4) :1194-1198.

14. Al-Khafaji S M, Al-janabi AM, Al-ghzaly B, Faris S A. Genetic Aspect of Iraqi Pregnant Women with Pre-Eclampsia. International Journal of Science and Research. 2015; 4:1563-1567.

15. Nuha A. E., Grazia A., Vanita R. Aroda et al. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care 2023;46: S19-S40.

16. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016; 11:95–104.

17. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150–9.

18. Adiga US, Malawadi BN. Association of Diabetic Nephropathy and Liver Disorders. J Clin Diagn Res. 2016;10(10):05–7.

19. Di W., Liwei B., Qianqian Z. et. al. Association of MTHFR C677T and A1298C polymorphisms with the development of type 2 diabetic nephropathy and their interaction with environmental factors. Int J Clin Exp Pathol 2017;10 (3): 3778-3785.

20. Paul G. and Sreyoshi F.A.. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 2015; 10; 14:6.

21. AbdRaboh NR, Badr S, Ali S. Prevalence of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Egyptian patients with type 2 diabetes mellitus. Egyptian Journal of Medical Human Genetics 2013; 14:87-93. 22- Zhang X, Hou C, Liu P, Chen L, Liu Y, Tang P, Li R. Methylenetetrahydro-folate Reductase (MTHFR) C677T Polymorphism andSubacute Combined Degeneration: Revealing a Genetic Predisposition. Front Neurol. 2019; 9:1162.

22. Sun J, Xu Y, Zhu Y, Lu H. Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus. J Endocrinol Invest. 2006;29(9):814–20.

23. Zhou TB, Drummen GP, Jiang ZP, Li HY. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus. Ren Fail. 2015;37(8):1247-59.

Downloads

Published

2025-12-06

How to Cite

1.
Association of MTHFR gene polymorphism (rs1801133) with Type 2 Diabetic Iraqi population. JPMS [Internet]. 2025 Dec. 6 [cited 2026 Mar. 16];1(2). Available from: https://pms-journal.de/index.php/pms/article/view/22

Similar Articles

You may also start an advanced similarity search for this article.